Compare CleanSpark Inc (CLSK) vs Novo Nordisk A/S (NVO) Price & Performance

CleanSpark IncTrade

Novo Nordisk A/STrade

Price performance (Past 24H)

Key statistics

CleanSpark Inc vs Novo Nordisk A/S — how do they compare? CleanSpark Inc trades at $13.98 (market cap $3.45B), while Novo Nordisk A/S trades at $50.31 (market cap $214.94B). The key difference: Novo Nordisk A/S is far larger — about 62.3× CleanSpark Inc's market cap, and Novo Nordisk A/S pays a 3.67% dividend while CleanSpark Inc pays none. Which is the better fit depends on your goals.

	CLSK	NVO
Market Cap	$3.45B	$214.94B
Sector	Technology	Health
52-Week High	$23.20	$71.70
52-Week Low	$8.18	$35.29
Enterprise Value	$4.31B	$233.91B
Dividend Yield	—	3.67%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CleanSpark Inc

CleanSpark (CLSK) trades at $12.36, down 3.81% today, with a bearish technical signal and recent earnings misses. The company reported a net loss margin of -67.66% for 2026 but announced a transformative $6.6 billion 20-year AI data center lease, shifting focus from Bitcoin mining to high-performance computing. Analyst consensus remains unanimously bullish with a $21.43 price target, highlighting growth potential despite current profitability challenges.

The outlook balances high growth potential from the AI pivot against significant execution risks and persistent losses. Near-term volatility is expected as the market assesses the company's ability to monetize new contracts and achieve sustainable profitability. The stock presents a high-risk, high-reward opportunity dependent on successful business model transition.

Novo Nordisk A/S

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

CLSK

CleanSpark gains strong buy rating on AI-driven pivot and major HPC deal boosting growth potentialSeeking Alpha · 8 hours agoBullish CleanSpark shares jump 12% on $6.6B data center lease deal with global tech firmProactive Investors · 1 day agoBullish CleanSpark inks $6.6B 20-year lease with top tech firm, expanding data center footprint in Georgia and Texas.PRNewsWire · 1 day agoBullish View details →

NVO

Global blood glucose monitoring market to nearly double to $39.4B by 2035 with 8.9% CAGR driven by AI and home care trendsCustom Market Insights · 1 day agoBullish Vivani develops semaglutide implant to improve long-term weight loss adherence for GLP-1 usersCNBC · 4 days agoBullish View details →

About CleanSpark Inc

CleanSpark is a leading Bitcoin mining company that operates high-density data centers. It focuses on using sustainable energy to power its mining fleet and provides digital infrastructure for the blockchain ecosystem.

About Novo Nordisk A/S

With almost 50% market share by volume of the global insulin market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments, and oral antidiabetic agents. Novo also has a biopharmaceutical segment (constituting roughly 15% of revenue) that specializes in protein therapies for hemophilia and other disorders.